Press release
Global Thalassemia Market Size – Forecast to 2026
Thalassemia Market Size – Forecast to 2026
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on “Global Thalassemia Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138
By Therapeutic Class (Iron Chelating Drugs), By Pipeline (Gene Therapy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis.
Key Market Insights
• An increasing number of patented medicines and targeted therapies for thalassemia treatment would boost the global thalassemia market.
• Iron chelation prevents iron toxicity complications such as heart and hepatic malfunction which makes it a perfect therapeutic class for thalassemia.
• Gene therapy enables successful exvivo genetic alteration of human stem cells, which can result in hemoglobin synthesis and a significant therapeutic advantage in thalassemia patients.
• The increasing number of thalassemia patients in the U.S is expected to propel the North American market forward.
• Acceleron Pharma, Inc., Bluebird Bio, Inc., CRISPR Therapeutics, La Jolla Pharmaceutical Company, Incyte Corporation, IONIS Pharmaceuticals, GlaxoSmithKline plc., Kiadis Pharma, Lonza Group AG, Alnylam Pharmaceuticals Inc, Sangamo Bioscience, Calimmune Inc, Gamida Cell Ltd, Editas Medicine Inc, Pharma Essentia Corp, Gilead Sciences Inc, Merck & Co Inc, Zydus Cadila Healthcare Ltd, Protagonist Therapeutics Inc, and others, are major players of thalassemia market.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138
Therapeutic Class Outlook (Revenue, USD Billion, 2021-2026)
• Iron Chelating Drugs
Pipeline Outlook (Revenue, USD Billion, 2021-2026)
• Gene Therapy
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Thalassemia Market Size – Forecast to 2026 here
News-ID: 2286141 • Views: …
More Releases from Global Market Estimates Research & Consultants
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029.
Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market Insights
• As per…
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029.
Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market…
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029.
Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded…
Global Asset Management Solution Market Size & Trends
According to a new market research report published by Global Market Estimates, the global asset management solution market is projected to grow at a CAGR of 35.1% from 2024 to 2029.
The growth of the global asset management solution market is driven by increasing demand for efficient and automated asset tracking and management, the growing need for compliance and risk management in various industries (IoT), and the expanding adoption of cloud-based…
More Releases for Thalassemia
Thalassemia Market to Witness Growth Acceleration | SG Pharma Pvt. Lmt.
The Thalassemia Market Report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each region and country involved in the study. Furthermore, It studies the market essential sectors such as top participants, expansion strategies, business models, and other industry features to improve the current strategy of key players. Facts and data are presented in reports using diagrams, graphs, pie charts, and other pictorial representations.…
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy…
Global Thalassemia Market: Industry Analysis & Outlook (2017-2021)
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Thalassemia Market: Industry Analysis & Outlook (2017-2021)” report studies Thalassemia is a blood disorder that causes abnormal production of hemoglobin in an affected person. It is a genetic disorder inherited from parents. Hemoglobin carries oxygen in the blood and is produced by two proteins called alpha globin and beta globin.…
Thalassemia - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure to thrive, poor appetite and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow…
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms…
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia…
